Cargando…
2138. Evaluating the Safety and Immunogenicity of the rZIKV/D4Δ30-713 Live Attenuated Chimeric Zika Candidate Vaccine in Healthy Flavivirus-Naïve Adults
BACKGROUND: Zika virus (ZIKV) is a flavivirus associated with a serious congenital Zika syndrome, with a recent epidemic originating in Brazil in 2015. Novel ZIKV vaccine candidates are in development. We report results of a phase I study of the first live attenuated ZIKV vaccine for use in humans....
Autores principales: | Zhong, Diana, Kirkpatrick, Beth, Pierce, Kristen, Patel, Urvi, Blunt, Madeleine R, Durbin, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752575/ http://dx.doi.org/10.1093/ofid/ofac492.1758 |
Ejemplares similares
-
Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil
por: Calvet, Guilherme Amaral, et al.
Publicado: (2018) -
Coinfection with Zika Virus (ZIKV) and Dengue Virus Results in Preferential ZIKV Transmission by Vector Bite to Vertebrate Host
por: Chaves, Barbara Aparecida, et al.
Publicado: (2018) -
Overview of Zika virus (ZIKV) infection in regards to the Brazilian
epidemic
por: Slavov, S.N., et al.
Publicado: (2016) -
Analysis of methyltransferase (MTase) domain from Zika virus (ZIKV)
por: Afaq, Sarah, et al.
Publicado: (2020) -
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003
por: Tu, Huy A., et al.
Publicado: (2020)